通过智能手机自我管理应用程序改善喘控制和生活质量:一个随机对照试验
Mehrdad Farzandipour1, Marzieh Heidarzadeh Arani2, Reihane Sharif1
1Health Information Management Research Center, Kashan University of Medical Sciences, Kashan, Iran; Department of Health Information Management and Technology, Allied Medical Sciences Faculty, Kashan University of Medical Sciences, Kashan, Iran.
Respiratory medicine
|February 7, 2024
概括
一个智能手机喘应用程序在六个月后显著改善了患者的喘控制和生活质量. 基于指导方针的移动健康应用程序提供了一种有希望的方法来增强喘自我管理.
科学领域:
- 数字健康数字健康
- 呼吸系统医学 呼吸系统医学
- 移动卫生干预行动 移动卫生干预行动
背景情况:
- 手机应用程序 (APP) 显示了改善喘自我管理的潜力.
- 然而,这些应用程序的有效性可能会有很大的不同.
- 这项研究调查了特定智能手机喘应用程序对患者结果的影响.
研究的目的:
- 为了评估基于智能手机的喘自我管理应用程序的有效性.
- 评估应用程序对喘控制和生活质量的影响.
- 为了比较应用程序用户和接受通常护理的对照组之间的结果.
主要方法:
- 一项单盲随机对照试验与60名喘患者进行.
- 参与者被区块随机分为干预组 (应用+常规护理) 或对照组 (常规护理).
- 喘控制测试 (ACT) 和喘生活质量问卷标记 (AQLQ-M) 在基线,3个月和6个月进行.
主要成果:
- 这两组从基线显示出喘控制和生活质量的改善.
- 与对照组相比,干预组在6个月的随访中表现出明显更大的改善 (p < 0.05).
- 反复测量ANOVA表明干预组的ACT和AQLQ-M得分随时间的推移发生了显著的积极变化 (p < 0.001).
结论:
- 基于智能手机的喘自我管理应用程序可以提高喘控制和生活质量.
- 基于指导方针的喘应用程序的使用在六个月后带来了优异的结果,与单独的通常护理相比.
- 这些发现支持将喘管理应用程序纳入临床实践.
相关概念视频
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298